White Andrew

Risk Factors for Rapid Glaucoma Disease Progression.

Cardiovascular disease is an important risk factor for rapid glaucoma disease progression irrespective of IOP control.

Modulation of Fibroblasts in Conjunctival Wound Healing.

The search for novel and more targeted means to control conjunctival fibrosis without such limitations has brought much attention to the regulation of fibroblast proliferation, differentiation, extracellular matrix production, and apoptosis.

Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery.

Twenty-four-month outcomes showed sustained IOP reduction with a good safety profile for both groups.

Outcomes and Baseline Predictors of Failure in Primary Standalone Xen45 Gel Stent versus Trabeculectomy for Glaucoma.

There was significantly greater complete success at 12 months across all complete success definitions for Trab compared with Xen, whereas the rate of postoperative hypotony was significantly lower in the Xen group.

Determining patient preferences in a glaucoma service: A discrete choice experiment.

Expertise and continuity of care were important to glaucoma patients in this setting, and they were willing to pay out-of-pocket and concede longer waiting times to secure these preferences.

Long-term comparative outcomes of Hydrus versus iStent inject microinvasive glaucoma surgery implants combined with cataract surgery.

There was no significant difference in surgical success between phaco-Hydrus and phaco-iStent groups at 48 months.

Association Between Prior Selective Laser Trabeculoplasty and Phaco-iStent Inject Efficacy.

In this observational study, prior SLT was associated with an increased risk of failure after phaco-iStent inject surgery.

Glaucoma referrals to a tertiary care glaucoma service in Australia.

Fifteen-Year Incidence of Open-Angle Glaucoma: The Blue Mountains Eye Study.

This study documented the 15-year incidence of OAG and associated risk factors in an older Australian population.

A Novel, Low-Cost Alternative to Traditional Glaucoma Surgeries.

This design represents a novel, low-cost, effective alternative to traditional glaucoma tube devices.

Pilocarpine test may predict success of argon laser peripheral iridoplasty.

Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.

The Xen 45 gel stent implant offers acceptable long-term efficacy for the treatment of open-angle glaucoma.

Reply.